PTK2 and neoplasm: Its expression level not only is inversely linked to patient survival but also positions FAK as a pivotal target for thwarting tumor progression and curbing recurrence (Zeng et al., 2016; Kanteti et al., 2018; Aboubakar et al., 2019a; Aboubakar et al., 2019b; Qiao et al., 2020; Wei et al., 2021; Roy-Luzarraga et al., 2022).